{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:54:59Z","timestamp":1782240899260,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although metabolic acidosis is known as a potential complication of chronic kidney disease (CKD), there is limited information concerning the association between metabolic acidosis and clinical outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Five hundred fifty-two patients referred to renal division of Iwata City Hospital from 2015 to 2017 were included as a retrospective CKD cohort, and finally 178 patients with CKD stage III or IV and 20 to 80\u2009years of age were analyzed. We examined the association between serum bicarbonate (HCO<jats:sub>3<\/jats:sub><jats:sup>\u2212<\/jats:sup>) levels and clinical outcomes using Kaplan-Meier methods after the matching of baseline characteristics by propensity scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 178 patients with CKD, patients with lower HCO<jats:sub>3<\/jats:sub><jats:sup>\u2212<\/jats:sup> levels (<jats:italic>N<\/jats:italic>\u2009=\u200994), as compared with patients with higher HCO<jats:sub>3<\/jats:sub><jats:sup>\u2212<\/jats:sup> levels (<jats:italic>N<\/jats:italic>\u2009=\u200984), were more likely to be male (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), had more severe CKD stages (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), more frequent use of renin-angiotensin system inhibitor (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) or uric acid lowering agent (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), heavier body weight (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and lower estimated glomerular filtration rate (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). In Kaplan-Meier analysis after propensity score matching, the incidence of composite outcome as the doubling of serum creatinine level from baseline, end-stage kidney disease requiring the initiation of dialysis, or death from any causes was significantly fewer in the higher HCO<jats:sub>3<\/jats:sub><jats:sup>\u2212<\/jats:sup> group than the lower HCO<jats:sub>3<\/jats:sub><jats:sup>\u2212<\/jats:sup> group (<jats:italic>N<\/jats:italic>\u2009=\u200957 each group, <jats:italic>P<\/jats:italic>\u2009=\u20090.016).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Lower HCO<jats:sub>3<\/jats:sub><jats:sup>\u2212<\/jats:sup> level is significantly associated with the doubling of serum creatinine level, end-stage kidney disease or all-cause mortality in patients with CKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>This study was registered with the Clinical Trial Registry of the University Hospital Medical Information Network (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.umin.ac.jp\/\">http:\/\/www.umin.ac.jp\/<\/jats:ext-link>, study number: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr\/ctr_view.cgi?recptno=R000051242\">UMIN000044861<\/jats:ext-link>).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02712-y","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T06:02:49Z","timestamp":1646373769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Lower bicarbonate level is associated with CKD progression and all-cause mortality: a propensity score matching analysis"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-4801","authenticated-orcid":false,"given":"Hirotaka","family":"Fukasawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"2712_CR1","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.2215\/CJN.07400715","volume":"10","author":"LL Hamm","year":"2015","unstructured":"Hamm LL, Nakhoul N, Hering-Smith KS. Acid-Base Homeostasis. Clin J Am Soc Nephrol. 2015;10:2232\u201342.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2712_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1053\/j.ajkd.2015.08.028","volume":"67","author":"JA Kraut","year":"2016","unstructured":"Kraut JA, Madias NE. Metabolic acidosis of CKD: an update. Am J Kidney Dis. 2016;67:307\u201317.","journal-title":"Am J Kidney Dis"},{"key":"2712_CR3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1053\/j.ackd.2017.06.006","volume":"24","author":"N Goraya","year":"2017","unstructured":"Goraya N, Wesson DE. Management of the Metabolic Acidosis of chronic kidney disease. Adv Chronic Kidney Dis. 2017;24:298\u2013304.","journal-title":"Adv Chronic Kidney Dis"},{"key":"2712_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/MNH.0b013e32833b64fa","volume":"19","author":"MM Yaqoob","year":"2010","unstructured":"Yaqoob MM. Acidosis and progression of chronic kidney disease. Curr Opin Nephrol Hypertens. 2010;19:489\u201392.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2712_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1053\/j.ajkd.2009.02.014","volume":"54","author":"SN Shah","year":"2009","unstructured":"Shah SN, Abramowitz M, Hostetter TH, Melamed ML. Serum bicarbonate levels and the progression of kidney disease: a cohort study. Am J Kidney Dis. 2009;54:270\u20137.","journal-title":"Am J Kidney Dis"},{"key":"2712_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ki.2010.388","volume":"79","author":"KL Raphael","year":"2011","unstructured":"Raphael KL, Wei G, Baird BC, Greene T, Beddhu S. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int. 2011;79:356\u201362.","journal-title":"Kidney Int"},{"key":"2712_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","volume":"62","author":"M Dobre","year":"2013","unstructured":"Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, et al. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis. 2013;62:670\u20138.","journal-title":"Am J Kidney Dis"},{"key":"2712_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5049\/EBP.2014.12.2.80","volume":"12","author":"J Jeong","year":"2014","unstructured":"Jeong J, Kwon SK, Kim HY. Effect of bicarbonate supplementation on renal function and nutritional indices in predialysis advanced chronic kidney disease. Electrolyte Blood Press. 2014;12:80\u20137.","journal-title":"Electrolyte Blood Press"},{"key":"2712_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1038\/ki.2014.83","volume":"86","author":"N Goraya","year":"2014","unstructured":"Goraya N, Simoni J, Jo CH, Wesson DE. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int. 2014;86:1031\u20138.","journal-title":"Kidney Int"},{"key":"2712_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2215\/CJN.06600619","volume":"15","author":"KL Raphael","year":"2020","unstructured":"Raphael KL, Greene T, Wei G, Bullshoe T, Tuttle K, Cheung AK, et al. Sodium bicarbonate supplementation and urinary TGF-beta1 in nonacidotic diabetic kidney disease: a randomized, controlled trial. Clin J Am Soc Nephrol. 2020;15:200\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2712_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Improving Global Outcomes (KDIGO) CKD Work Group. KDOGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kiney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kiney Int Suppl"},{"key":"2712_CR12","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1681\/ASN.2019070677","volume":"31","author":"DE Wesson","year":"2020","unstructured":"Wesson DE, Buysse JM, Bushinsky DA. Mechanisms of metabolic acidosis-induced kidney injury in chronic kidney disease. J Am Soc Nephrol. 2020;31:469\u201382.","journal-title":"J Am Soc Nephrol"},{"key":"2712_CR13","first-page":"889","volume":"276","author":"AF Connors Jr","year":"1996","unstructured":"Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators JAMA. 1996;276:889\u201397.","journal-title":"SUPPORT Investigators JAMA"},{"key":"2712_CR14","doi-asserted-by":"publisher","first-page":"e0145506","DOI":"10.1371\/journal.pone.0145506","volume":"10","author":"S Uchida","year":"2015","unstructured":"Uchida S, Chang WX, Ota T, Tamura Y, Shiraishi T, Kumagai T, et al. Targeting uric acid and the inhibition of progression to end-stage renal disease--a propensity score analysis. PLoS One. 2015;10:e0145506.","journal-title":"PLoS One"},{"key":"2712_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.ki.5002647","volume":"73","author":"S Phisitkul","year":"2008","unstructured":"Phisitkul S, Hacker C, Simoni J, Tran RM, Wesson DE. Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors. Kidney Int. 2008;73:192\u20139.","journal-title":"Kidney Int"},{"key":"2712_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ki.2009.6","volume":"75","author":"DE Wesson","year":"2009","unstructured":"Wesson DE, Simoni J. Increased tissue acid mediates a progressive decline in the glomerular filtration rate of animals with reduced nephron mass. Kidney Int. 2009;75:929\u201335.","journal-title":"Kidney Int"},{"key":"2712_CR17","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1681\/ASN.2008111205","volume":"20","author":"I de Brito-Ashurst","year":"2009","unstructured":"de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20:2075\u201384.","journal-title":"J Am Soc Nephrol"},{"key":"2712_CR18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S0272-6386(12)80344-1","volume":"17","author":"KA Nath","year":"1991","unstructured":"Nath KA, Hostetter MK, Hostetter TH. Increased ammoniagenesis as a determinant of progressive renal injury. Am J Kidney Dis. 1991;17:654\u20137.","journal-title":"Am J Kidney Dis"},{"key":"2712_CR19","doi-asserted-by":"publisher","first-page":"F830","DOI":"10.1152\/ajprenal.00587.2010","volume":"300","author":"DE Wesson","year":"2011","unstructured":"Wesson DE, Simoni J, Broglio K, Sheather S. Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone. Am J Physiol Renal Physiol. 2011;300:F830\u20137.","journal-title":"Am J Physiol Renal Physiol"},{"key":"2712_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/ndt\/gfu388","volume":"30","author":"DE Wesson","year":"2015","unstructured":"Wesson DE, Jo CH, Simoni J. Angiotensin II-mediated GFR decline in subtotal nephrectomy is due to acid retention associated with reduced GFR. Nephrol Dial Transplant. 2015;30:762\u201370.","journal-title":"Nephrol Dial Transplant"},{"key":"2712_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0272-6386(89)80200-8","volume":"14","author":"ML Halperin","year":"1989","unstructured":"Halperin ML, Ethier JH, Kamel KS. Ammonium excretion in chronic metabolic acidosis: benefits and risks. Am J Kidney Dis. 1989;14:267\u201371.","journal-title":"Am J Kidney Dis"},{"key":"2712_CR22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1681\/ASN.2017040422","volume":"29","author":"KL Raphael","year":"2018","unstructured":"Raphael KL. Metabolic acidosis and subclinical metabolic acidosis in CKD. J Am Soc Nephrol. 2018;29:376\u201382.","journal-title":"J Am Soc Nephrol"},{"key":"2712_CR23","doi-asserted-by":"publisher","first-page":"F502","DOI":"10.1152\/ajprenal.00044.2019","volume":"317","author":"N Goraya","year":"2019","unstructured":"Goraya N, Simoni J, Sager LN, Mamun A, Madias NE, Wesson DE. Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease. Am J Physiol Renal Physiol. 2019;317:F502\u2013F11.","journal-title":"Am J Physiol Renal Physiol."},{"key":"2712_CR24","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.kint.2018.11.033","volume":"95","author":"N Goraya","year":"2019","unstructured":"Goraya N, Simoni J, Sager LN, Madias NE, Wesson DE. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis. Kidney Int. 2019;95:1190\u20136.","journal-title":"Kidney Int"},{"key":"2712_CR25","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.2215\/CJN.03730411","volume":"6","author":"SD Navaneethan","year":"2011","unstructured":"Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Wehbe E, Raina R, et al. Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:2395\u2013402.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2712_CR26","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ki.2010.129","volume":"78","author":"A Mahajan","year":"2010","unstructured":"Mahajan A, Simoni J, Sheather SJ, Broglio KR, Rajab MH, Wesson DE. Daily oral sodium bicarbonate preserves glomerular filtration rate by slowing its decline in early hypertensive nephropathy. Kidney Int. 2010;78:303\u20139.","journal-title":"Kidney Int"},{"key":"2712_CR27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12882-021-02330-0","volume":"22","author":"H Morooka","year":"2021","unstructured":"Morooka H, Yamamoto J, Tanaka A, Inaguma D, Maruyama S. Relationship between mortality and use of sodium bicarbonate at the time of dialysis initiation: a prospective observational study. BMC Nephrol. 2021;22:118.","journal-title":"BMC Nephrol"},{"key":"2712_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1053\/j.ajkd.2004.09.034","volume":"45","author":"S Kobayashi","year":"2005","unstructured":"Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis. 2005;45:275\u201380.","journal-title":"Am J Kidney Dis"},{"key":"2712_CR29","first-page":"795","volume":"2008","author":"V Rajan","year":"1782","unstructured":"Rajan V, Mitch WE. Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease. Biochim Biophys Acta. 1782;2008:795\u20139.","journal-title":"Biochim Biophys Acta"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02712-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02712-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02712-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T06:04:07Z","timestamp":1646373847000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02712-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2712"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02712-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]},"assertion":[{"value":"12 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional ethics committee of Iwata City Hospital (approval number: 2021\u2013020) and conducted in accordance with the Declaration of Helsinki. Because of its retrospective nature, informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}